# Ibandronate Sodium

NDC: 65862-237
Generic name: Ibandronate Sodium
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20160311

FDA application: ANDA204502

## Active ingredients

- IBANDRONATE SODIUM: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-237"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-237
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=86c0b4ae-5e38-4efe-88af-50ac560e294f